Indeed, stimulation of the NF-κB signaling pathway promotes angiogenic neovascularization, epithelial-to-mesenchymal transition (EMT) and increases cancer cell stemness, leading to chemoresistance, radioresistance and endocrine resistance. Here, NFKB1 is linked to cancer.